Belgium· BE-AMP-SAM179042-00
Sular-10 10 mg
A nisoldipine product containing nisoldipine, registered in Belgium by Bayer. The same ATC class is registered in 4 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Nisoldipine is registered in 4 of 19 countries.
Countries holding a registration under ATC C08CA07 (nisoldipine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Nisoldipine · ATC C08CA07
4 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Nisoldipine
- Manufacturer
- Bayer
- Country
- Belgium (BE)
- ATC code
- C08CA07
- ATC class
- Nisoldipine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
- be_apb1304245
- be_apb1304252
- be_apb0749507
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
230 interactions on record for nisoldipine.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nisoldipine · interactions on record
230 records
- 10 severe
- 168 moderate
- 5 minor
- 46 info
Most severe, free to view
- DolasetronA04AA04severe
- KetoconazoleH02CA03severe
- KetoconazoleJ02AB02severe
- CeritinibL01ED02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nisoldipine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15496dd6-e710-45e5-94b9-e96165c81025 GET /v1/drugs/15496dd6-e710-45e5-94b9-e96165c81025?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prolonged-release tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Sular-10 10 mg",
"name_fr": "Sular-10 10 mg",
"name_nl": "Sular-10 10 mg",
"amp_code": "SAM179042-00",
"strengths": [
"10.0000"
],
"pack_count": 3,
"substances": [
"Nisoldipine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Nisoldipine",
"authorisation_numbers": [
"BE179042"
]
}See everything about nisoldipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.